Business Wire

Cmed Clinical Services Appoints New Chief Medical Officer

9.10.2015 11:03 | Business Wire

Del

Cmed Clinical Services, an innovative, full service CRO providing services to the Biopharma industry worldwide, announced today the appointment of Dr. Bams Abila, MD, PhD, FFPM, to Chief Medical Officer.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151009005298/en/

Dr. Bams Abila, Chief Medical Officer, Cmed Clinical Services (Photo: Business Wire)

Dr. Bams Abila, Chief Medical Officer, Cmed Clinical Services (Photo: Business Wire)

In this role, Dr. Abila will be responsible for leading the development and operation of Cmed’s medical function, providing leadership and strategic guidance on medical and scientific matters. He will also provide general support and training to the medical and consulting groups across Cmed to ensure the safe, legal, ethical and optimal drug development design and conduct of clinical studies. He will be based in the UK and brings to Cmed a wealth of experience in the design and delivery of clinical strategies and clinical studies with small molecules and biologicals across several therapy areas in Phases I-III.

“We are delighted to welcome Bams Abila to Cmed” said Dr. David Connelly, Cmed’s CEO. “Bams brings a vast amount of expertise, knowledge and skills in translational medicine, clinical development and drug safety, which will be very valuable not only to Cmed in driving our plans for future growth, but for our clients in maintaining and enhancing the design and conduct of their clinical trials. Bams also has a deep interest in the use of advanced data technologies to enhance the speed and efficiency of drug development which fits very well with the evolution of Cmed’s technology division.”

Dr. Abila has 10 years academic medical research experience and extensive global drug development experience spanning 25 years across several therapeutic areas within pharmaceutical settings, including Aventis, Pfizer, Astellas, AstraZeneca and GSK. He is the Founder and Principal Consultant in Pharmaceutical Medicine of Clintreq Consultancy Ltd, working with both pharmaceutical and biotech companies. He is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians (UK), Fellow of the Royal Society of Medicine (UK) and is a Member of the British Association of Pharmaceutical Physicians, the British Pharmacological Society and the American Heart Association. He is also a member of the American Society of Clinical Pharmacology and was a founding member of the society’s Biologics Community.

- ends -

About Cmed

Cmed is an innovative full service CRO and a software developer of smart e-clinical data capture and management technologies. Cmed was established in 2000 with the vision to conduct clinical trials better than anyone else, thus saving and helping lives. Cmed has a focus on bringing innovation to the design and conduct of clinical trials, including in the areas of clinical data capture, data management, monitoring. Cmed has two divisions: Cmed Clinical Services and Cmed Technology.

Cmed Clinical Services is a global CRO providing services to the Biopharma industry worldwide. Cmed works with clients to not only deliver the clinical trial services effectively, and with quality, passion, teamwork and superior customer service, but also, especially for full service projects, by understanding the clients commercial and business objectives. Cmed then leverages its in-depth expertise to ensure the development program and/or clinical trial is well designed and conducted as efficiently and as cost effectively as possible. Cmed has particular expertise in the design and conduct of complex, oncology and rare disease trials and the provision of Biometric functional services.

Cmed Technology designed and developed Timaeus: a unique single platform for electronic trial design, paper & electronic data capture, monitoring, coding, data management and reporting. Using distributed cloud computing and mobile technologies, Timaeus has been deployed in over 400 clinical trials and has successfully passed multiple audits. The unique Timaeus design provides a number of benefits to our clients including rapid database build (weeks not months), mid-trial updates without down-time and non-reliance on the internet. These benefits lead to many advantages including the removal of EDC build from study start-up, no restriction on investigator site selection, no negative impact on recruitment timelines due to design changes, and elevated investigator motivation.

Contact information

Cmed
Anna Forster, Marketing Manager
aforster@cmedresearch.com
+44(0)1403 755050

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Out-of-this-World Science Project to be Featured as Keynote at SC17’s High Performance Computing Conference in Denver16.8.2017 13:00Pressemelding

Professor Philip Diamond, Director General of the international Square Kilometer Array (SKA) project, will be the keynote speaker at SC17, the International Conference for High Performance Computing, Networking, Storage and Analysis in Denver, Nov. 12-17. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005129/en/ SC17 Keynote Speaker Philip Diamond (Photo: Business Wire) SKA is an international collaboration to build the world’s largest radio telescope that will change our understanding of space as we know it. Professor Diamond, accompanied by Dr. Rosie Bolton, SKA Regional Centre Project Scientist, will take SC17 attendees around the globe and out into the deepest reaches of the observable universe as they describe the SKA’s international partnership that will map and study the e

Maxion Wheels to Feature Market Leading Commercial Vehicle Steel Wheels at COMTRANS 201716.8.2017 13:00Pressemelding

Maxion Wheels, the world’s largest wheel manufacturer, announced today its participation in the biennial COMTRANS / 17 International Commercial Vehicle Show held in Moscow, Russia from September 4 – 9, 2017, in Hall 15/ Stand 15-432. Customers and visitors to the Maxion Wheels exhibit will have the opportunity to learn more about the state-of-the-art commercial vehicle steel wheels that have supported the success of global original equipment manufacturers for almost 100 years. One of the key products on display will be the new 8.5” x 24” wheel for tubeless tire applications in Russia, the Middle East and Africa. The wheel boasts 15 percent less weight than the prior generation wheel, enhancing tire life and improving fuel efficiency. ABOUT MAXION WHEELS Maxion Wheels, a division of IOCHPE-MAXION S.A., is a leading wheel manufacturer for passenger cars,

Scientist.com Ranks No. 155 on the 2017 Inc. 5000 List of Fastest-Growing Companies16.8.2017 12:06Pressemelding

Scientist.com, the leading marketplace for outsourced scientific services, today announced that it ranked no. 155 on Inc. magazine’s 2017 List of the 5000 Fastest-Growing privately-owned companies in America, and it ranked no. 11 in the country in the Health category. The San Diego-based company builds private marketplaces that connect many of the world’s largest life science research organizations with a global network of thousands of research suppliers. “Using Scientist.com, research organizations of pharmaceutical companies, biotech start-ups and academic and research institutes can get near instant access to thousands of the latest research technologies and services,” stated Paul A. Stone, JD, Partner at 5AM Ventures, a Scientist.com investor. “The marketplace saves researchers time, reduces costs, promotes access to innovation and ensures regulatory compliance. Scientist.com is im

CMB Successfully Goes-Live on Murex’s MX.3 Platform16.8.2017 08:00Pressemelding

Murex, a global leader in trading, risk management and processing solutions, is pleased to announce the successful launch of the MX.3 platform at China Merchants Bank (CMB). As one of China’s largest commercial banks, CMB financial market department currently averages 8,000 trades per day with a portfolio of 320,000 live trades on MX.3. CMB decided to launch the project to implement an enterprise-wide solution for their capital markets teams based in Shenzhen and Shanghai. This was done in order to improve control over their end-to-end trading cycle from front-to-back through risk, streamline and automate their operations, and enable new business. Murex’s MX.3 platform was selected as it provided the functional, geographical and product coverage that was required by the bank. Covering Front Office, Processing, Finance, and Risk Management, MX.3 also provides VaR analytics across all asset

euNetworks Adds New High Density Fibre Network in Manchester16.8.2017 08:00Pressemelding

euNetworks, a provider of bandwidth services in Europe, today announced it has made further investment in Manchester in the United Kingdom, having built out a new high density fibre network covering over 40 route kilometres in the city. This follows initial expansion into Manchester’s MediaCityUK in May 2016, which supported euNetworks’ Media customer’s bandwidth needs, as well as enabling a seamless network experience from London through to Manchester and Dublin and onwards to Europe. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005067/en/ euNetworks Fibre in Manchester (Photo: Business Wire) This new network in Manchester city was designed for resilience, with fully diverse nodes. euNetworks undertook a combination of new construction and duct acquisition to complete this network

The Peninsula Classics Best of the Best Award for 2016 Awarded to 1954 Maserati A6GCS/53 Berlinetta by Pinin Farina16.8.2017 07:28Pressemelding

At a highly-anticipated private gathering during the famed Monterey Car Week, a 1954 Maserati A6GCS/53 Berlinetta by Pinin Farina, from the Monaco-based Destriero Collection, was named winner of the prestigious second-annual The Peninsula Classics Best of the Best Award . This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005384/en/ 1954 Maserati A6GCS/53 Berlinetta by Pinin Farina was named winner of the prestigious The Peninsula Classics Best of the Best Award. Photo Credit: Adam Swords Only four Berlinetta-bodied sports cars from Pinin Farina were ever produced, and this exquisite model is considered to be the best preserved, as it is the only one that retains its original chassis and body. Custom ordered by the Roman dealer of the marque, the sports car is

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom